title: Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
authors.forename: James M
authors.initials: JM
authors.lastname: Perrin
authors.forename: Richard A
authors.initials: RA
authors.lastname: Friedman
authors.forename: Timothy K
authors.initials: TK
authors.lastname: Knilans
mesh_terms: D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000150:complications / Q000175:diagnosis* / Q000401:mortality; D000697:Central Nervous System Stimulants / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008991:Monitoring, Physiologic / Q000379:methods; D011050:Policy Making; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012955:Societies, Medical
chemical_list: D000697:Central Nervous System Stimulants